Skip to content

Insmed INSM Gross Profit

Discontinued — last reported Q1 '26

Gross Profit at other companies

ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$143.88M+16.0%
Innoviva, Inc. logo
Innoviva, Inc.INVA
$75.83M+3.4%
Mannkind logo
MannkindMNKD
$82.66M+10.8%
United Therapeutics logo
United TherapeuticsUTHR

Other financials

Income statement

See full
Revenue$306.0M+230%
Operating income-$153.3M+38.2%
Net income-$163.6M+36.3%
EPS (diluted)-$0.76+46.5%

Balance sheet

See full
Cash & equivalents$582.2M+44.4%
Total debt$580.3M-49.2%
Total equity$704.9M+611%
Total assets$2.1B+15.2%

Cash flow

See full
Operating cash flow-$222.7M+15.0%
CapEx$3.5M-65.4%
Free cash flow-$226.2M+16.9%

Valuation

See full
Market cap$23.11B+25.2%
Enterprise value$23.11B+29.9%
P/S28.2×-18.2×

Profitability

See full
Gross margin81.8%+5.3pp
Operating margin-140.6%-43.9pp
Net margin-144.4%-45.3pp
FCF margin-112.5%-35.3pp

Returns & leverage

See full
Return on equity-294.5%
Debt / equity0.8×-10.7×
Current ratio4.5×-1.4×

Where this comes from

Calculated from Insmed’s reported figures.

The official record: Insmed’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Insmed's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Insmed's gross profit?
Insmed (INSM) reported gross profit of $258.54M in Q1 2026.
How has Insmed's gross profit changed year-over-year?
Insmed's gross profit increased by 261.4% year-over-year, from $71.55M to $258.54M.
What is the long-term trend for Insmed's gross profit?
Over 4 years (2021 to 2025), Insmed's gross profit has grown at a 35.3% compound annual growth rate (CAGR), from $144.31M to $483.49M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.